Shalby Ltd

Shalby Ltd Share Price Today: Live Updates & Key Insights

Get insights on Shalby Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Shalby Ltd Share Price Chart

SHALBY at 10 Jul 2026 06:06 PM Healthcare Facilities

171.56 +1.98(+1.17%)

Lowest Today 170.00

Highest Today 172.58

Today's Open 170.20

Prev. Close 169.58

52 Week High 274.70

52 Week Low 125.82

Shalby Ltd Fundamentals

Traded Volume: 24,694

Market Cap(Cr): 1,853.02

Avg Traded Price 171.33

1 Year return -6.68%

Upper Circuit 172.6

Lower Circuit 170

P/E TTM 50.00

P/B Ratio 1.814

Traded Value(Cr) 42.37

EPS TTM 3.462

Book value/Share 93.490

Dividend Yield 1Y 0.00%

Shalby Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Shalby Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Shalby Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -1.24%

1M +1.46%

3M +13.73%

1Y -6.68%

YTD -16.45%

Shalby Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Shalby Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 59078.00

Day Before Yesterday 1.18L

1W Avg 76047.60

1M Avg 76182.33

3M Avg 97221.16

Shalby Ltd Technical Details

Shalby Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 170

Support 2 169

Support 3 168

Pivot Point : 171

Resistance 1 173

Resistance 2 174

Resistance 3 175

Shalby Ltd Corporate Actions

Shalby Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Shalby Ltd’s capital allocation strategies.

All

Ex-Date 19-Sep-2024 Type D Description 1.20/share@12.00% Record Date - Ratio 12.00

Ex-Date 08-Aug-2023 Type D Description 1.20/share@12.00% Record Date - Ratio 12.00

Ex-Date 19-Sep-2022 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Ex-Date 17-Sep-2021 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Ex-Date 04-Sep-2020 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00

Ex-Date 16-Aug-2019 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00

Dividends

Announcement Date 19-Sep-2024 Ex Dividend Date 19-Sep-2024 Dividend(%) 12

Announcement Date 08-Aug-2023 Ex Dividend Date 08-Aug-2023 Dividend(%) 12

Announcement Date 19-Sep-2022 Ex Dividend Date 19-Sep-2022 Dividend(%) 10

Announcement Date 17-Sep-2021 Ex Dividend Date 17-Sep-2021 Dividend(%) 10

Announcement Date 04-Sep-2020 Ex Dividend Date 04-Sep-2020 Dividend(%) 5

Announcement Date 16-Aug-2019 Ex Dividend Date 16-Aug-2019 Dividend(%) 5

Bonus

No Bonus has been declared by SHALBY

Splits

No Split has been declared by SHALBY

Others

Rights No Rights has been declared by SHALBY

Shalby Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Shalby Ltd with leading peers in the healthcare sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Shalby Ltd's relative performance and valuation against major competitors.

Stock Name Indraprastha Medical Corporation Ltd ₹380.85 (+0.32%) M. Cap (Cr) 34.91 1 Yr Return (%) -22.73% P/E (TTM) 19.01 PB Ratio 4.72

Stock Name Dr Agarwals Eye Hospital Ltd ₹4902.50 (-2.18%) M. Cap (Cr) 23.69 1 Yr Return (%) +9.21% P/E (TTM) 32.89 PB Ratio 6.66

Stock Name KMC Speciality Hospitals (India) Ltd ₹135.05 (-0.88%) M. Cap (Cr) 22.03 1 Yr Return (%) +106.15% P/E (TTM) 47.13 PB Ratio 10.47

Stock Name Shalby Ltd ₹171.56 (+1.17%) M. Cap (Cr) 18.53 1 Yr Return (%) -6.68% P/E (TTM) 49.56 PB Ratio 1.84

Stock Name GPT Healthcare Ltd ₹158.11 (-0.13%) M. Cap (Cr) 12.97 1 Yr Return (%) -1.00% P/E (TTM) 30.73 PB Ratio 4.82

Stock Name Gujarat Kidney & Super Speciality Ltd ₹132.55 (+1.20%) M. Cap (Cr) 10.45 1 Yr Return (%) NaN% P/E (TTM) 67.44 PB Ratio 4.14

Stock Name KRM Ayurveda Ltd ₹259.00 (+1.27%) M. Cap (Cr) 5.51 1 Yr Return (%) NaN% P/E (TTM) 27.37 PB Ratio 4.80

Shalby Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Shalby Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2026 128.16 Mar 2025 148.82 Mar 2024 139.77 Mar 2023 164.53 Mar 2022 100.98

PARTICULARS Investing Activities Mar 2026 -108.60 Mar 2025 -100.63 Mar 2024 -206.00 Mar 2023 -172.40 Mar 2022 -40.32

PARTICULARS Financing Activities Mar 2026 -27.80 Mar 2025 -35.80 Mar 2024 72.14 Mar 2023 -38.21 Mar 2022 -17.25

PARTICULARS Net Cash Flow Mar 2026 -8.25 Mar 2025 12.40 Mar 2024 5.91 Mar 2023 -46.09 Mar 2022 43.41

Shalby Ltd Shareholding Pattern

This shows the ownership breakdown of Shalby Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 74.33%

Public 20.41%

Other Institutions 0.25%

FII 4.36%

Mutual Funds N/A%

About Shalby Ltd

Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004. Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006. Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services. With 15 hospitals and over 2,300 beds across 12 cities, Shalby is now the largest corporate hospital group in Western and Central India. The Hospitals are tertiary care hospitals, few of which offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. Led by Dr. Vikram Shah, an orthopaedic surgeon, the Hospital has grown from a single hospital to a chain of multi-specialty hospitals. Apart from orthopaedics, the hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology. The Hospitals, Krishna Shalby, SG Shalby, Shalby Indore and Shalby Jabalpur are accredited by the NABH. Further, Krishna Shalby and SG Shalby are also accredited by the NABL. The Hospital currently runs a pan-Indian chain of 11 multispecialty tertiary hospitals and 4 Single specialty Hospitals (SOCE) across 6 states with a total bed capacity of more than 2,000. Shalby has 59 outpatient clinics (OPDs) across 16 states. It also expanded global presence by opening OPDs in Kenya, Nairobi, Ethiopia, Tanzania, and Uganda in the African continent.In 2007, the Company established operations of its first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad. The company commenced a new hospital Shalby Vapi at Vapi in April 2012 and thereafter it commenced a new hospital Krishna Shalby in Ahmedabad in October 2012. The company commenced a new hospital Shalby Jabalpur at Jabalpur in Madhya Pradesh in March 2015. The company commenced a new hospital Shalby Indore at Indore in August 2015. In 2016, the company executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby. During the year under review, the company executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali. In 2017, the company entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries. The Company came up with an Initial Public Offer of 20,354,838 Equity Shares by raising capital from public aggregating to Rs 504. 8 Crores comprising a Fresh Issue of 19,354,838 Equity Shares amounting to Rs 480 Crores and an Offer for Sale of 1,000,000 Equity Shares amounting to Rs 24.8 Crore in December, 2017.With the increase in demand of digital transformation in healthcare sector, Shalby embarked its journey of digital transformation across its all hospitals from 2018-19. In 2020, the Company launched Video Assisted Thoracic Surgery (VATS) to reduce the incidence of surgical complications. The Liver Transplant Facility became fully operational at Shalby, Ahmedabad and Mohali.The Company incorporated a new wholly owned subsidiary Company under the name and style `Mars Medical Devices Limited' on April 3, 2020. The Company also incorporated wholly-owned subsidiary company under the name and style `Shalby Hospitals Mumbai Pvt. Ltd.' on December 10, 2020. In May 2021, the Company acquired the assets of Consensus Orthopaedics, a hip and knee implant manufacturing company with its facility at El Dorado Hills, USA. The Company also commenced multi-speciality rehabilitation centre at one of its Unit in 2021. The Company launched a state-of-the-art `Digital Spine Operation Room' at SG Shalby Hospital, Ahmedabad in 2022. In September 2021, the Company launched its first Shalby Orthopedics Centre of Excellence (SOCE) in the country at Udaipur. Centralised cloud based Laboratory Information System (LIS) was launched in 2022. The Company further incorporated Shalby Advanced Technologies Inc. (SAT) in the first quarter of Fiscal 2022.In 2022-23, the Company launched a new product line of Uni Knee System called as Tahoe Unicompartmental Knee System or TUKS.It acquired 87.26% stake in PK Healthcare Pvt Ltd (Sanar International Hospital-130 beds) in FY 2024, making it a subsidiary of the Company and further acquired 100% stake in Healers Hospital Pvt Ltd at Gurugram costing Rs 104 Crore. Company further has established new SOCE in Ranchi having 60 beds in 2024.The new Rajkot SOCE unit became operational from July 2024. The Company opened major units at Indore and other hospitals to strengthen the super-speciality capabilities, supported by the hiring of 40 doctors focused on high-end procedures. Sanar Shalby Hospital in Gurugram, enhanced a Centre of Excellence (CoE) for liver transplants, bone marrow transplants, CT transplants and complex procedures in FY 2025.

Chairman / Executive Director / M D / Promoter

Vikram Shah

Registered office Opp Karnawati Club, Sarkhej Gandhinagar Highway, Ahmedabad, Gujarat, 380015

FAX :91-79-40203000

Background

Incorporation Year 2004

Face Value ₹10.00

Market Lot 1

Shalby Ltd Latest News

VIEW MORE NEWS

FAQs on Shalby Ltd